CLL-Cell Proliferation Measured by In Vivo Deuterium Labeling in Early Stage Patients and Correlation with Other Prognostic Markers.

MLA

Murphy, Elizabeth J., et al. “CLL-Cell Proliferation Measured by In Vivo Deuterium Labeling in Early Stage Patients and Correlation with Other Prognostic Markers.” Blood, vol. 110, no. 11, Nov. 2007, p. 3088. EBSCOhost, https://doi.org/10.1182/blood.V110.11.3088.3088.

APA

Murphy, E. J., Hayes, G., Rassenti, L. Z., Voogt, J., Zent, C. S., Lin, T., Weirda, W., Greaves, A., Prado, K., Hellerstein, M. K., Chiorazzi, N., Kipps, T. J., & Rai, K. R. (2007). CLL-Cell Proliferation Measured by In Vivo Deuterium Labeling in Early Stage Patients and Correlation with Other Prognostic Markers. Blood, 110(11), 3088. https://doi.org/10.1182/blood.V110.11.3088.3088

Chicago

Murphy, Elizabeth J., G. Hayes, L.Z. Rassenti, J. Voogt, C.S. Zent, T. Lin, W. Weirda, et al. 2007. “CLL-Cell Proliferation Measured by In Vivo Deuterium Labeling in Early Stage Patients and Correlation with Other Prognostic Markers.” Blood 110 (11): 3088. doi:10.1182/blood.V110.11.3088.3088.